Evidence map›Paper›PMID 28988996›Full record

ArticleMicrobes and infection2018

2017: beginning of a new era for Chlamydia research in China and the rest of the world.

Huizhou Fan, Guangming Zhong

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbes and infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Huizhou FanDepartment of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA. Electronic address: huizhou.fan@rutgers.edu.
Guangming ZhongDepartment of Microbiology, Immunology and Molecular Genetics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. Electronic address: zhongg@uthscsa.edu.

Funding

Chlamydial plasmid-dependent pathogenesisR01AI121989 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHONG, GUANGMING · 2016 to 2019
$1.9M
GrgA: Key Regulator of Chlamydial Physiology and potential Antichlamydial TargetR21AI122034 · NIAID · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI FAN, HUIZHOU · 2016 to 2017
$414k
NIAID NIH HHS R01 AI121989NIAID NIH HHS R21 AI122034
6 · The paper itself

Abstract

The First Chinese Chlamydia Research Meeting was held in Lanzhou, China in May 2017, 60 years after the disclosure of reproducible isolation of Chlamydia trachomatis by (Fei-fan Tang). We report current state of the Chlamydia research community in China, and briefly review recent progress in Chlamydia vaccinology. The meeting represents a new milestone for Chlamydia research in the country. The Chinese Chlamydia Research Society (CCRS) was formed during the meeting. Future meetings will be held biennially and should facilitate collaboration of Chinese researchers with their domestic and international colleagues.

Indexed as

AnimalsChinaChlamydia InfectionsChlamydia trachomatisHumansResearchViral VaccinesViral VaccinesChlamydia trachomatisInfertilityPelvic inflammatory diseaseSexually transmitted infectionTrachomaVaccine

Identifiers

PMID28988996
PMCPMC5819738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.